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Introduction
Malaria parasites are successful single cell pathogens that cause immense morbidity and mortality in humans and other vertebrates. They have complex life cycles, but asexual replication within host erythrocytes is responsible for most clinical sequelae of malaria.
Plasmodium falciparum, the most virulent human pathogen, remodels its host erythrocyte by exporting proteins (Boddey et al., 2010; Russo et al., 2010) , generating membrane-bound organelles within the host cytosol (Tamez et al., 2008) , and increasing erythrocyte permeability to numerous solutes (Ginsburg et al., 1983; Kirk et al., 1994) .
The increased permeability is mediated by ion channels at the host erythrocyte membrane; it has been studied with tracer flux (Homewood and Neame, 1974; Saliba et al., 1998) , osmotic fragility (Kutner et al., 1987) , and patch-clamp techniques (Alkhalil et al., 2004; Staines et al., 2007; Alkhalil et al., 2012) . Although several different channels have been proposed, recent studies with highly specific inhibitors support a single broad selectivity ion channel known as the plasmodial surface anion channel, PSAC (Pillai et al., 2010) . PSAC has an unusually small single channel conductance for a broad selectivity channel (20 pS in 1.1 M Cl -) and is functionally conserved in divergent plasmodial species (Lisk and Desai, 2005) . Two clag3 genes from the parasite have been implicated in this channel activity through a molecular cloning strategy using an isolate-specific PSAC antagonist, ISPA-28, that blocks channels from only the Dd2 parasite line (Nguitragool et al., 2011) .
Although direct evidence is missing, circumstantial observations suggest that PSAC activity is essential for intraerythrocytic parasite survival. First, both channel activity and the clag gene family are conserved in all plasmodial species examined to date (Lisk and Desai, 2005; Kaneko et al., 2001) . Single channel patch-clamp studies have determined that even biophysical properties such as ion channel gating, conductance, and functional copy number/cell are nearly
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identical in P. falciparum and P. knowlesi, two divergent malaria parasites (Lisk and Desai, 2005) . Second, gene silencing and mono-allelic expression of clag3 genes in P. falciparum suggest that channel function is important (Cortes et al., 2007) : parasites invest in expression switching for key gene families to evade host immunity and protect essential activities at the host cell surface (Scherf et al., 2008) . Third, quantitative permeability studies for some required nutrients suggest that their PSAC-mediated uptake is needed for in vitro parasite cultivation (Gero and Wood, 1991; Saliba et al., 1998; Liu et al., 2006; Martin and Kirk, 2007) . Finally, selections of parasite cultures with permeant toxins has generated functional PSAC mutants Lisk et al., 2008 ), but has not yielded complete loss of function. These mutant channels exhibit reduced toxin uptake, but appear to satisfy the parasite's transport demands.
Nevertheless, it remains possible that channel activity is a non-essential byproduct of host cell invasion (Staines et al., 2007) . If the channel is required for parasite survival, the physiological role(s) it serves are debated, with proposals including nutrient uptake and metabolic waste removal (Desai et al., 2000) , modification of host erythrocyte ionic composition (Brand et al., 2003) , volume regulation of the infected cell (Staines et al., 2001; Lew et al., 2004) , and autocrine purinergic signaling (Akkaya et al., 2009 ).
We have now addressed these uncertainties with functional and molecular studies using ISPA-28. This and other PSAC inhibitors exhibit improved efficacy in parasite growth inhibition studies when the concentrations of key nutrients are reduced. Genetic mapping, DNA transfection, and in vitro selections implicate the clag3 genes in channel-mediated nutrient uptake required for parasite survival within erythrocytes.
This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Parasite cultivation, design of PGIM, and growth inhibition studies. Asexual stage P.
falciparum laboratory lines were propagated by standard methods in RPMI 1640 supplemented with 25 mM HEPES, 31 mM NaHCO 3 , 0.37 mM hypoxanthine, 10 µg/mL gentamicin, and 10% pooled human serum. Nutrient deprivation experiments followed this standard medium, but used reduced concentrations of individual constituents; human serum was exhaustively dialyzed against distilled H 2 0 prior to addition to these media. PGIM contains reduced concentrations of isoleucine (11.4 µM), glutamine (102 µM), and hypoxanthine (3.01 µM) and was also supplemented with dialyzed serum.
Growth inhibition experiments were quantified using a SYBR Green I-based fluorescence assay for parasite nucleic acid in 96-well microplates, as described previously (Pillai et al., 2010) . Ring-stage synchronized cultures were seeded at 1% parasitemia and 2% hematocrit in standard medium or PGIM and maintained for 72 h at 37 o C in 5% O 2 , 5% CO 2 without media change. Cultures were then lysed in 20 mM Tris, 10 mM EDTA, 0.016% saponin, and 1.6% triton X100, pH 7.5 with SYBR Green I nucleic acid gel stain at a 5,000x dilution (Invitrogen, Carlsbad, CA). After a 45 min incubation, parasite DNA content was quantified by measuring fluorescence (excitation/emission wavelengths, 485/528 nm). For each inhibitor concentration, the mean of triplicate measurements was calculated after subtraction of background fluorescence from matched cultures killed by 20 μ M chloroquine. Growth inhibition studies with the HB3 3rec parasite were performed after transport-based selection with ISPA-28 to achieve expression of the chimeric clag3 gene generated by allelic exchange transfection. Limiting dilution culture to obtain parasite clones was performed in 96-well microplates with detection of positive wells by the C-SNARF method (Lyko et al., 2012) .
This article has not been copyedited and formatted. The final version may differ from this version. Parasites were also cultivated in pooled human serum collected from non-fasting donors (Interstate Blood Bank, Memphis, TN). The serum was ultracentrifuged (300,000 x g, 1h) to remove buoyant lipoproteins and used in 72 h cultivation experiments in microplates as above.
Growth was quantified as above, except that microplate wells were washed once with PBS prior to addition of buffered SYBR Green I gel stain to eliminate serum-associated fluorescence artifacts.
Transport inhibition assays. Inhibitor affinity for PSAC block was determined using a quantitative transmittance assay based on osmotic lysis of infected cells in sorbitol (Pillai et al., 2010) . Parasite cultures were enriched at the trophozoite stage using the percoll-sorbitol method, washed, and resuspended at 37 o C and 0.15% hematocrit in 280 mM sorbitol, 20 mM Na-HEPES, 0.1 mg/ml BSA, pH 7.4 with indicated inhibitor concentrations. Osmotic lysis due to PSAC-mediated sorbitol uptake was continuously tracked with transmittance measurements through the cell suspension (700 nm wavelength, DU640 spectrophotometer with Peltier temperature control, Beckman Coulter, Brea, CA). Inhibitor dose responses were calculated from the time required to reach a fractional lysis threshold. ISPA-28 dose responses were fitted to the sum of two Langmuir isotherms:
where P represents the normalized sorbitol permeability in the presence of inhibitor at concentration x, and a, b, and c are constants. Dose responses for other inhibitors were adequately fitted by a single Langmuir isotherm. (Wellems et al., 1990 ) using 448 previously selected polymorphic markers that distinguish the Dd2 and HB3 parental lines (Nguitragool et al., 2011) .
QTL analysis was performed using R/qtl software (freely available at http://www.rqtl.org/) as described (Broman et al., 2003) and conditions suitable for the haploid asexual parasite. A P = 0.5 significance threshold was estimated with permutation analysis. Growth inhibition data at 0.3 and 10 µM ISPA-28 identified the same locus we report with 3 µM ISPA-28. Additional QTL were sought with secondary scans by controlling for the clag3 locus.
Quantitative RT-PCR. Two-step real-time PCR was used to quantify clag gene expression using allele-specific primers developed previously (Nguitragool et al., 2011 supplemented with 10% fetal calf serum. Cell viability was quantified using the vital stain MTS
inner salt], as described (Marshall et al., 1995) . The reported CC 50 value is the concentration of an inhibitor that reduces conversion of MTS to formazan by 50%.
Results
Poor growth inhibition by ISPA-28 under standard culture conditions. ISPA-28 blocks PSAC on Dd2-infected cells with high affinity and has only weak activity against channels from We considered possible explanations and determined that ISPA-28 efficacy against Dd2 channels is not compromised by metabolism of the inhibitor under in vitro culture conditions (Supplemental Fig. 1A ). ISPA-28 is also not significantly adsorbed by serum protein or lipids, a phenomenon known to reduce activity of some PSAC inhibitors and many therapeutics (Supplemental Fig. 1B-D ; Matsuhisa et al., 1987) . Thus, ISPA-28 has unexpectedly poor efficacy against growth of Dd2 parasites.
One possibility is that channel activity is essential for malaria parasites, but that low level transport remaining in the presence of inhibitor adequately meets parasite demands under standard in vitro culture conditions. Consistent with this, we noticed sustained channel-mediated uptake in Dd2-infected erythrocytes even with high ISPA-28 concentrations; significantly less
residual uptake was observed with compound 2, a broad spectrum PSAC inhibitor with a comparable inhibitory K 0.5 value for Dd2 channels (Supplemental Fig. 2 ; P < 10 -4 for comparison of these inhibitors at 10 µM). The unexpected difference in residual channel activity with these inhibitors may account for their differing efficacies against in vitro parasite growth (IC 50 values of >40 µM and 4.7 µM, respectively; Table 1 ).
Incomplete block with high ISPA-28 concentrations despite a low K 0.5 value for Dd2 channels suggests a complex mechanism of inhibition. While dantrolene and furosemide dose ISPA-28 inhibits growth of Dd2 but not of HB3 upon nutrient restriction. If PSAC functions in nutrient acquisition for the intracellular parasite (Desai et al., 2000) , then the incomplete inhibition by ISPA-28 may permit adequate nutrient uptake. This effect may be accentuated under in vitro culture using RPMI 1640-based formulations, which contain high nutrient concentrations to support growth of diverse cell lines (Sato and Kan, 2001) . The large inward concentration gradient for nutrients in such media may sustain parasite nutrient uptake despite near-complete channel block.
To evaluate this possibility, we examined parasite requirement for isoleucine, an essential amino acid that the parasite cannot synthesize de novo (Istvan et al., 2011) . Isoleucine is absent from human hemoglobin, which the parasite digests as a source of some amino acids; it must be MOL #81224
1 2 acquired by uptake from serum (Liu et al., 2006; Martin and Kirk, 2007 (EC 50 of 34.6 ± 1.1 µM; P < 10 -9 , Student's t test), but had no effect on HB3 parasites. This effect suggests an essential role for PSAC-mediated isoleucine uptake and is consistent with transport studies that show this channel is a major route of uptake after infection.
Because many nutritive solutes have significant PSAC permeability, we also examined parasite growth in RPMI-1640 media upon isolated removal of several other solutes: calcium panthothenate, cysteine, glutamic acid, glutamine, methionine, proline, and tyrosine.
Hypoxanthine, a purine source not present in RPMI 1640 but commonly added to parasite culture media, was also evaluated. Each of these solutes has documented PSAC permeability (Ginsburg et al., 1985; Asahi et al., 1996; Gero and Wood, 1991; Saliba et al., 1998; Lisk et al., 2006) , but some also exhibit uptake via host transporters on the erythrocyte membrane (Winterberg et al., 2012; Quashie et al., 2010) . Microscopic examination of parasites propagated in these single depletion experiments revealed the greatest detriment upon removal of glutamine and hypoxanthine, but short-term growth studies revealed relatively modest effects (Fig. 1B-C) .
Addition of ISPA-28 did not measurably increase Dd2 requirement of either solute in these experiments.
Because parasite growth reflects a complex interplay of multiple biochemical pathways and the availability of nutrients that feed into them, the effects of PSAC inhibition may be greater than predicted from deprivation studies restricted to single solutes. We therefore simultaneously varied concentrations of isoleucine, glutamine, and hypoxanthine without manipulating other This article has not been copyedited and formatted. The final version may differ from this version.
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1 3 constituents in the RPMI 1640-based medium. This approach revealed conditions that increased ISPA-28 potency against Dd2 parasites while preserving the compound's negligible effect against HB3 ( Fig. 2A ).
In the absence of transport inhibitors, this medium, termed PSAC Growth Inhibition Medium (PGIM), permitted continuous propagation of both Dd2 and HB3 parasites (> 2 weeks), though at somewhat reduced rates (Fig. 2B, black bars) . We noticed that cultures with low parasitemias grew well in PGIM but that rates decreased with higher parasite burden, consistent with nutrient limitation and competition amongst parasites in culture. To explore how these conditions may compare to in vivo expansion rates, we also examined parasite propagation in pooled, non-fasting serum collected from healthy donors. Human serum, when not subjected to dilution by synthetic media, also yielded relatively slow expansion of parasite cultures (Fig. 2B , white bars), consistent with the view that RPMI 1640-based formulations achieve high culture expansion rates through use of supraphysiological nutrient levels.
Linkage analysis and DNA transfection implicate clag3 genes and PSAC inhibition.
Although the ISPA-28 growth IC 50 values in PGIM (0.66 ± 0.20 µM and 52 ± 19 µM for Dd2 and HB3, respectively; P < 10 -4 ) agree reasonably well with this inhibitor's transport K 0.5 values, differing efficacies against parasite growth might also reflect the inhibitor's effects on other parasite targets. We therefore examined the ISPA-28 growth inhibition phenotype in the progeny of the Dd2 x HB3 genetic cross (Wellems et al., 1990) . These studies revealed a broad range of ISPA-28 efficacies for progeny clones (Fig. 2C) , with many progeny resembling one or the other parent. Because HB3 and some progeny had high growth IC 50 values that could not be precisely estimated, linkage analysis was performed using growth inhibition at 3 µM ISPA-28, a concentration that optimally distinguishes the parental phenotypes. This analysis identified a This article has not been copyedited and formatted. The final version may differ from this version. single parasite genomic locus at the 5' end of chromosome 3 with high confidence (Fig. 2D, LOD score of 12.7). Additional contributing genomic loci were sought by removing the effects of this locus, but were not identified in secondary scans (Supplemental Fig. 3 ). exhibits high affinity inhibition by ISPA-28 (K 0.5 of 51 ± 9 nM, P = 0.88 for no difference from Dd2; Nguitragool et al., 2011) . In PGIM-based growth inhibition studies, HB3 3rec was highly sensitive to ISPA-28 at levels that matched Dd2 parasites (Fig. 2E ), indicating that ISPA-28 toxicity is mediated through action on the clag3 product. Moreover, the requirement for nutrient restriction to detect this compound's growth inhibitory effect supports a primary role of PSAC in parasite nutrient acquisition.
Selective growth of parasites with resistant clag3 alleles. We explored the channel's role further by evaluating whether PSAC inhibitors and PGIM can be used to selectively kill parasites that express individual clag3 genes. Most laboratory parasite lines carry two clag3 genes on chromosome 3, but individual parasites appear to express only one allele at a time (Fig.   3A) . Silencing of the other allele is thought to occur via epigenetic mechanisms (Cortes et al., 2007) . This process, along with relatively slow rates of switching between the two alleles, allows subsets of parasites to escape host immune responses against surface-exposed antigens.
ISPA-28 specifically inhibits channels associated with the Dd2 clag3.1 gene because it binds to a region near the C-terminus of the encoded protein; it has little or no activity against channels This article has not been copyedited and formatted. The final version may differ from this version. (Nguitragool et al., 2011) . This inhibitor has previously been used to select for Dd2 clag3.1 expression through osmotic lysis of infected cells in sorbitol, a sugar alcohol with high PSAC permeability. Sorbitol solutions containing ISPA-28 select for this allele because osmotic lysis eliminates infected cells whose channels are not blocked (Fig. 3B, transport selection) .
Here, we hypothesized that ISPA-28 and PGIM may be useful in counter-selections for other clag3 alleles (Fig. 3B, PGIM The culture was then propagated in PGIM containing 5 µM ISPA-28 for a total of 10 days; microscopic examination of smears during this treatment revealed near complete sterilization of the culture. Channels expressed by parasites that survived this second treatment had markedly reduced ISPA-28 affinity, indicating that in vitro propagation with PSAC inhibitors can be used to select for rare parasite subpopulations. Consistent with our predictions, RT-PCR confirmed strong negative selection against clag3.1 to yield parasites that preferentially express clag3.2.
There were also modest changes in expression of clag genes on other chromosomes, suggesting that these paralogs may also contribute to PSAC activity. Importantly, the opposing effects of ISPA-28 on in vitro growth inhibition and on susceptibility to transport-induced osmotic lysis permit purifying selections of either clag3 allele and reveal a strict correlation with channel phenotype.
This article has not been copyedited and formatted. The final version may differ from this version. We next attempted negative selection with growth inhibition in PGIM containing ISPA-28.
After 2 cycles of drug pressure with 5 µM ISPA-28 for a total of 17 days, resistant cells were identified and characterized after limiting dilution to obtain the clone Dd2-PGIM28. Consistent with killing primarily via PSAC inhibition, transport studies using this resistant clone revealed a marked reduction in inhibitor affinity (Fig. 4A) . Surprisingly, although the ISPA-28 dose response quantitatively matched that of 7C20 parasites after identical PGIM-based selection (upper solid line, Fig. 4A ), full length clag3.2 transcript was still undetectable (Fig. 4B ).
Because this observation excludes simple gene switching, we considered spontaneous recombination between the two clag3 genes. We identified a chimeric clag3 transcript using a forward clag3.1 primer and a reverse clag3.2 primer; PCR confirmed that this chimera is present in the selected parasite's genome but absent from the original Dd2 line (Fig. 4C ). Southern blotting with a clag3 specific probe detected three discrete bands in the selected clone but only the expected two bands in unselected Dd2 parasites ( Fig. 4D ; Supplemental Fig. 5 showing probe specificity), implicating a recombination event to produce three clag3 genes in Dd2-PGIM28
This article has not been copyedited and formatted. The final version may differ from this version. We used quantitative RT-PCR to examine transcription of clag genes in Dd2-PGIM28 and found that the chimeric gene is preferentially expressed (Fig. 4F ; 8.9 ± 1.3 fold greater than clag3.1, P < 0.002). We then performed transport-based selection with sorbitol and ISPA-28 to examine whether Dd2-PGIM28 can undergo expression switching. As expected for an intact Thus, recombination between the two clag3 genes occurs with relative ease, consistent with reports of frequent recombination events in the parasite's subtelomeric regions (Freitas-Junior et al., 2000) . Such recombination events may serve to increase diversity in PSAC phenotypes, apparent here as affording survival of a parasite with three clag3 genes under selective pressure.
This article has not been copyedited and formatted. The final version may differ from this version. Fig. 1C-D) , but are approved therapeutics in other human diseases. They are only weakly effective against parasite growth in standard medium, but have significantly improved activity in PGIM. We also tested 8 high affinity PSAC inhibitors from 5 distinct scaffolds recently identified by high-throughput screening (Pillai et al., 2010) . Each of these inhibitors was also more potent when nutrient concentrations were reduced, strengthening the evidence for the channel's role in nutrient acquisition. The extent of improved efficacy was variable, but many compounds exhibited a >100-fold improvement in efficacy upon nutrient restriction (IC 50 ratio, Table 1 ). Factors such as the stoichiometry of inhibitor:channel interaction and resultant changes in the concentration dependence of channel block (Supplemental Fig. 2 ), compound stability in culture, and adsorption by serum may influence the magnitude of this ratio for individual compounds.
To explore therapeutic potential, we then examined in vitro HeLa cell cytotoxicity. Several potent PSAC inhibitors were found to be nontoxic ( Table 2 ), suggesting that they may be excellent starting points for medicinal chemistry optimization to develop new antimalarial drugs that target parasite nutrient uptake.
Finally, we performed in vitro growth inhibition experiments with chloroquine, mefloquine, and artemisinin, approved antimalarial drugs that work at unrelated targets within the intracellular parasite. Each of these drugs was modestly less active in PGIM than in standard medium (Table 1) conditions. The improved efficacy of PSAC inhibitors upon nutrient restriction is in contrast to the effect on existing antimalarial drugs and, therefore, implicates a distinct mechanism of action.
Discussion
Conservation of both PSAC activity and the recently implicated clag3 genes in rodent, avian, and primate malaria species suggests that this ion channel serves an important role for the intracellular parasite. Because the channel is absent from other apicomplexan parasites and higher organisms , inhibitors may be suitable starting points for development of highly specific antimalarial drugs. However, PSAC's biological role was unclear; concerns that the channel might be only an epiphenomenon of infection hampered progress toward therapeutics (Staines et al., 2007) . Here, we addressed this uncertainty with isolate-specific and broad spectrum PSAC inhibitors, linkage analysis in a genetic cross, molecular studies, and in vitro selections. These studies provide experimental evidence for an essential and targetable role of PSAC in nutrient acquisition for the intracellular parasite.
Previous growth inhibition studies with PSAC inhibitors have consistently reported discrepancies between the concentrations required for transport inhibition and those needed to inhibit in vitro parasite growth (Pillai et al., 2010; Staines et al., 2004) . In light of our findings, this discrepancy likely results from use of RPMI formulations, which were designed with high concentrations of many nutrients to maximize growth of diverse cell types. Our examination of individual substrates revealed that isoleucine uptake via PSAC serves an essential role for the parasite. Plasma isoleucine concentrations in developed countries range between 60 and 95 µM (Armstrong and Stave, 1973; Milsom et al., 1979) , with values in malarious countries likely to be lower (Saunders et al., 1967) . These measured values are not only significantly lower than the This article has not been copyedited and formatted. The final version may differ from this version. 
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2 0 381 µM in RPMI 1640, but they fall into a range where dose response studies suggest that PSAC-mediated uptake is rate-limiting (Fig. 1A) . Although glutamine and hypoxanthine dose response studies did not show similar effects on their own, their combined restriction to produce PGIM yielded further improvements in PSAC inhibitor efficacy. Future refinements of PGIM to include other permeant nutrients having high concentrations in RPMI 1640 may yield additionally improved in vitro PSAC inhibitor efficacy. Separate studies, such as in vivo efficacy studies in rodent malaria models, will be necessary to determine whether our findings can be translated into future antimalarial drugs.
Marked changes in inhibitor efficacy after relatively modest manipulations raise questions about the optimal conditions for high-throughput screens that use in vitro growth inhibition to find antimalarial drug leads; to date, these screens have used only the standard RPMI 1640 medium (Plouffe et al., 2008; Gamo et al., 2010; Guiguemde et al., 2010) . Although three existing antimalarial drugs had unchanged efficacy upon nutrient restriction (Table 1) , it is important to recognize that in vitro parasite growth depends on many factors. We envision that compounds acting at some downstream sites involved in nutrient utilization or metabolism will also exhibit improved efficacy in more physiological media such as PGIM. Such compounds may act synergistically with PSAC inhibitors. Future high-throughput screens that quantify parasite growth inhibition should consider the medium and other growth conditions carefully;
conditions that most closely reproduce in vivo parasite development may be fruitful.
While our studies provide additional evidence for the involvement of parasite clag3 genes in PSAC activity, there are still fundamental questions about the composition and structure of this unusual ion channel (Desai, 2012) . Prior studies of these genes are also largely consistent with our findings (Cortes et al., 2007; Vincensini et al., 2008; Kaneko et al., 2001) , but there are some interesting discrepancies with a reported clag3 knockdown parasite (Comeaux et al., 2011) . That
This article has not been copyedited and formatted. The final version may differ from this version. clag3 genes had undetectable expression in their study, their findings contrast with the essential role in nutrient uptake proposed here. PSAC activity remains to be examined in the knockdown parasite; molecular studies are also required to explore ectopic recombination or other compensatory changes that circumvent gene suppression (Fig. 4) . Another possibility, that only some parasite lines require channel-mediated nutrient uptake, may reconcile our findings with a viable clag3 knockdown parasite. In this case, surveys of clinical isolates from malaria patients may reveal novel PSAC-null parasite lines. Such studies should be pursued as they are complementary to in vivo efficacy studies in rodent malaria species.
Allele-specific inhibitors, such as ISPA-28, represent useful reagents for examining epigenetic silencing mechanisms. In addition to the clag3 genes, several other parasite gene families exhibit regulated expression and switching to increase antigenic diversity and achieve immune evasion (Scherf et al., 1998; Mok et al., 2007; Lavazec et al., 2007; Deitsch et al., 2009 ).
ISPA-28 is especially useful because it can be used in both positive and negative selections for the Dd2 clag3.1 gene: our transport and growth inhibition strategies permit selection of channels that are either sensitive or resistant to this inhibitor. By combining these strategies, we identified a defect in clag3 gene switching in the Dd2 line; intact switching in the 7C20 parasite, which is isogenic at the chromosome 3 locus, excludes defects in cis-regulatory elements such as the promoter and instead suggests other determinants, possibly transcription factors (Tonkin et al., 2009 (Kraemer and Smith, 2003) ; they likely account for the observed variation in clag3 copy number of common laboratory parasite lines (Chung et al., 2007) .
Our studies suggest that nutrient uptake at the host membrane is rate-limiting. Table 1 ). A legitimate concern relates to functional differences between channels of distinct parasite lines and associated polymorphisms in the clag3 product (Alkhalil et al., 2004; Alkhalil et al., 2009; Nguitragool et al., 2011) . Will such variability reduce clinical effectiveness against malaria or speed drug resistance? We do not think so.
Critical channel properties, such as the list of permeant solutes and their relative transport rates, are strictly conserved in P. falciparum and other malaria parasite species (Lisk and Desai, 2005) .
Paralleling this observation, informatic analyses of the clag3 product reveal highly conserved domains separated by only a few polymorphic regions. In addition to sites that function in solute recognition and permeation, domains that function in trafficking, insertion, and regulation of the channel at the host erythrocyte surface may also be conserved and, therefore, targetable.
This article has not been copyedited and formatted. The final version may differ from this version. trials from up to 3 independent experiments; black and red symbols correspond to experiments without and with addition of 15 µM ISPA-28, respectively. Solid lines represent best fit of data to sigmoidal growth curves. Note that ISPA-28 significantly increases Dd2 demand for isoleucine, but has no effect on that of HB3 parasites. Ethidium-stained gels showing RT-PCR amplicons for expression of native clag3 genes ("3.1" and "3.2") or chimeric genes resulting from recombination ("3.1f-3.2r" and "3.2f-3.1r"). 
